Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusion

British Journal of Anaesthesia

Volumn 112, Issue 3, 2014, Pages 576-577

  Palomero Rodriguez M A ^a   Laporta Baez Y ^a   Sanchez Conde M P ^a   Mollinedo, F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; ARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; ORNITHINE; OXYHEMOGLOBIN; UREA;

BLOOD STORAGE; BLOOD TRANSFUSION; CANCER GROWTH; CANCER RECURRENCE; CELL DEATH; ERYTHROCYTE CONCENTRATE; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LETTER; LEUKOCYTE; NEUTROPHIL; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; TUMOR ESCAPE;

BLOOD TRANSFUSION; HUMANS; IMMUNE TOLERANCE; NEOPLASMS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84896873483     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aeu024     Document Type: Letter

References (5)

1. Cata JP, Wang H, Gottumukkala V, Reuben J, Sessler DI. Inflammatory response immunosuppression and cancer recurrence after peri-operative blood transfusions. Br J Anaesth 2013; 110: 690-701
2. Atzil S, Arad M, Glasner A, et al. Blood transfusion promotes cancer progression: a critical role for aged erythrocytes. Anesthesiology 2008; 109: 989-97
3. Berra L, Coppadoro A, Yu B, et al. Transfusion of stored autologous blood does not alter reactive hyperemia index inhealthy volunteers. Anesthesiology 2012; 117: 56-63
4. Munder M, Mollinedo F, Calafat J, et al. Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity. Blood 2005; 105: 2549-56
5. Mollinedo F, Palomero-Rodriguez MA, Sanchez-Conde MP, et al. Arginase as a new concern in blood transfusion. Blood Transfus 2013: 1-2